Selective Restriction of Nef-Defective Human Immunodeficiency Virus Type 1 by a Proteasome-Dependent Mechanism
Open Access
- 1 February 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (3) , 1534-1536
- https://doi.org/10.1128/jvi.02099-06
Abstract
The Nef protein enhances human immunodeficiency virus type 1 (HIV-1) infectivity by facilitating an early postentry step in the virus life cycle. We report here that the addition of MG132 or lactacystin, each a specific inhibitor of cellular proteasome activity, preferentially enhances cellular permissiveness to infection by Nef-defective versus wild-type HIV-1. Pseudotyping by the glycoprotein of vesicular stomatitis virus rendered Nef-defective HIV-1 particles minimally responsive to the enhancing effects of proteasome inhibitors. These results suggest that Nef enhances the infectivity of HIV-1 particles by reducing their susceptibility to proteasomal degradation in target cells.Keywords
This publication has 17 references indexed in Scilit:
- Functional characterization of HIV-1 Nef mutants in the context of viral infectionVirology, 2006
- Inhibition of Lysosome and Proteasome Function Enhances Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2005
- HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusionVirology, 2004
- Disruption of the Actin Cytoskeleton Can Complement the Ability of Nef To Enhance Human Immunodeficiency Virus Type 1 InfectivityJournal of Virology, 2004
- HIV-1 Nef Enhances Both Membrane Expression and Virion Incorporation of Env ProductsJournal of Biological Chemistry, 2004
- The Membrane-Proximal Tyrosine-Based Sorting Signal of Human Immunodeficiency Virus Type 1 gp41 Is Required for Optimal Viral InfectivityJournal of Virology, 2004
- Nef Does Not Affect the Efficiency of Human Immunodeficiency Virus Type 1 Fusion with Target CellsJournal of Virology, 2003
- Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low pH No Longer Require Nef for Optimal InfectivityJournal of Virology, 2001
- The Growth Advantage Conferred by HIV-1 nef Is Determined at the Level of Viral DNA Formation and Is Independent of CD4 DownregulationVirology, 1995
- The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.The Journal of Experimental Medicine, 1994